vs
CANTALOUPE, INC.（CTLP）与Phathom Pharmaceuticals, Inc.（PHAT）财务数据对比。点击上方公司名可切换其他公司
CANTALOUPE, INC.的季度营收约是Phathom Pharmaceuticals, Inc.的1.4倍（$78.7M vs $57.6M），Phathom Pharmaceuticals, Inc.同比增速更快（94.1% vs 6.8%），CANTALOUPE, INC.自由现金流更多（$-614.0K vs $-167.0M）
坎塔卢波（原美国技术公司）是一家美国科技企业，核心业务为ePort无现金支付受理技术，依托持专利的PCI合规ePort Connect服务开展运营。该服务可通过无线方式为消费者提供信用卡、借记卡以及Apple Pay、Google Pay等NFC钱包支付选项，同时为运营商提供遥测与机器间通信服务，ePort技术主要应用于...
Phathom Pharmaceuticals是一家临床阶段生物制药公司，专注于研发和商业化胃肠道疾病的创新疗法，其核心候选产品针对酸相关疾病、炎症性肠病等适应症，主要服务北美及欧洲地区的患者群体。
CTLP vs PHAT — 直观对比
营收规模更大
CTLP
是对方的1.4倍
$57.6M
营收增速更快
PHAT
高出87.4%
6.8%
自由现金流更多
CTLP
多$166.4M
$-167.0M
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $78.7M | $57.6M |
| 净利润 | $-70.0K | — |
| 毛利率 | — | 86.7% |
| 营业利润率 | 2.0% | — |
| 净利率 | -0.1% | — |
| 营收同比 | 6.8% | 94.1% |
| 净利润同比 | -101.4% | 71.6% |
| 每股收益（稀释后） | $0.00 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTLPPHAT
| Q4 25 | $78.7M | $57.6M | ||
| Q3 25 | $80.9M | $49.5M | ||
| Q2 25 | $82.6M | $39.5M | ||
| Q1 25 | $75.4M | $28.5M | ||
| Q4 24 | $73.7M | $29.7M | ||
| Q3 24 | $70.8M | $16.4M | ||
| Q2 24 | $72.7M | $7.3M | ||
| Q1 24 | $67.9M | — |
净利润CTLPPHAT
| Q4 25 | $-70.0K | — | ||
| Q3 25 | $-919.0K | $-30.0M | ||
| Q2 25 | $6.8M | $-75.8M | ||
| Q1 25 | $49.2M | $-94.3M | ||
| Q4 24 | $5.0M | — | ||
| Q3 24 | $3.6M | $-85.6M | ||
| Q2 24 | $2.2M | $-91.4M | ||
| Q1 24 | $4.7M | — |
毛利率CTLPPHAT
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 87.5% | ||
| Q2 25 | — | 87.2% | ||
| Q1 25 | — | 86.9% | ||
| Q4 24 | — | 87.1% | ||
| Q3 24 | — | 85.6% | ||
| Q2 24 | — | 81.2% | ||
| Q1 24 | 39.6% | — |
营业利润率CTLPPHAT
| Q4 25 | 2.0% | — | ||
| Q3 25 | 2.0% | -30.8% | ||
| Q2 25 | 6.3% | -151.7% | ||
| Q1 25 | 9.1% | -276.5% | ||
| Q4 24 | 8.4% | — | ||
| Q3 24 | 5.8% | -433.0% | ||
| Q2 24 | 4.9% | -1055.4% | ||
| Q1 24 | 6.3% | — |
净利率CTLPPHAT
| Q4 25 | -0.1% | — | ||
| Q3 25 | -1.1% | -60.5% | ||
| Q2 25 | 8.3% | -191.9% | ||
| Q1 25 | 65.2% | -330.7% | ||
| Q4 24 | 6.7% | — | ||
| Q3 24 | 5.0% | -523.3% | ||
| Q2 24 | 3.0% | -1248.6% | ||
| Q1 24 | 6.9% | — |
每股收益（稀释后）CTLPPHAT
| Q4 25 | $0.00 | — | ||
| Q3 25 | $-0.02 | $-0.41 | ||
| Q2 25 | $0.10 | $-1.05 | ||
| Q1 25 | $0.65 | $-1.31 | ||
| Q4 24 | $0.07 | — | ||
| Q3 24 | $0.04 | $-1.32 | ||
| Q2 24 | $0.03 | $-1.56 | ||
| Q1 24 | $0.06 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $53.0M | $130.0M |
| 总债务越低越好 | $37.7M | $209.1M |
| 股东权益账面价值 | $252.5M | $-438.2M |
| 总资产 | $381.9M | $259.1M |
| 负债/权益比越低杠杆越低 | 0.15× | — |
8季度趋势，按日历期对齐
现金及短期投资CTLPPHAT
| Q4 25 | $53.0M | $130.0M | ||
| Q3 25 | $55.0M | $135.2M | ||
| Q2 25 | $51.1M | $149.6M | ||
| Q1 25 | $46.3M | $212.3M | ||
| Q4 24 | $27.7M | $297.3M | ||
| Q3 24 | $33.1M | $334.7M | ||
| Q2 24 | $58.9M | $276.2M | ||
| Q1 24 | $50.2M | — |
总债务CTLPPHAT
| Q4 25 | $37.7M | $209.1M | ||
| Q3 25 | $38.3M | $207.1M | ||
| Q2 25 | $38.7M | $205.1M | ||
| Q1 25 | $39.2M | $203.2M | ||
| Q4 24 | $37.0M | $201.4M | ||
| Q3 24 | $37.3M | $175.7M | ||
| Q2 24 | $37.5M | $174.4M | ||
| Q1 24 | $38.1M | — |
股东权益CTLPPHAT
| Q4 25 | $252.5M | $-438.2M | ||
| Q3 25 | $251.8M | $-422.5M | ||
| Q2 25 | $251.0M | $-405.8M | ||
| Q1 25 | $240.7M | $-338.4M | ||
| Q4 24 | $190.1M | $-253.6M | ||
| Q3 24 | $186.2M | $-187.1M | ||
| Q2 24 | $181.7M | $-233.8M | ||
| Q1 24 | $178.8M | — |
总资产CTLPPHAT
| Q4 25 | $381.9M | $259.1M | ||
| Q3 25 | $389.5M | $240.3M | ||
| Q2 25 | $381.9M | $250.2M | ||
| Q1 25 | $370.5M | $294.2M | ||
| Q4 24 | $303.0M | $378.3M | ||
| Q3 24 | $312.1M | $387.0M | ||
| Q2 24 | $335.6M | $319.4M | ||
| Q1 24 | $319.9M | — |
负债/权益比CTLPPHAT
| Q4 25 | 0.15× | — | ||
| Q3 25 | 0.15× | — | ||
| Q2 25 | 0.15× | — | ||
| Q1 25 | 0.16× | — | ||
| Q4 24 | 0.19× | — | ||
| Q3 24 | 0.20× | — | ||
| Q2 24 | 0.21× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.1M | $-166.8M |
| 自由现金流经营现金流 - 资本支出 | $-614.0K | $-167.0M |
| 自由现金流率自由现金流/营收 | -0.8% | -290.0% |
| 资本支出强度资本支出/营收 | 4.8% | 0.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $25.8M | $-328.9M |
8季度趋势，按日历期对齐
经营现金流CTLPPHAT
| Q4 25 | $3.1M | $-166.8M | ||
| Q3 25 | $7.0M | $-14.1M | ||
| Q2 25 | $9.4M | $-62.7M | ||
| Q1 25 | $22.4M | $-84.9M | ||
| Q4 24 | $522.0K | $-266.8M | ||
| Q3 24 | $-12.0M | $-63.6M | ||
| Q2 24 | $14.3M | $-70.7M | ||
| Q1 24 | $14.7M | — |
自由现金流CTLPPHAT
| Q4 25 | $-614.0K | $-167.0M | ||
| Q3 25 | $3.5M | $-14.1M | ||
| Q2 25 | $4.3M | $-62.8M | ||
| Q1 25 | $18.6M | $-84.9M | ||
| Q4 24 | $-3.8M | $-266.9M | ||
| Q3 24 | $-15.8M | $-63.6M | ||
| Q2 24 | $8.5M | $-70.8M | ||
| Q1 24 | $11.4M | — |
自由现金流率CTLPPHAT
| Q4 25 | -0.8% | -290.0% | ||
| Q3 25 | 4.4% | -28.6% | ||
| Q2 25 | 5.3% | -159.0% | ||
| Q1 25 | 24.6% | -297.9% | ||
| Q4 24 | -5.1% | -899.8% | ||
| Q3 24 | -22.3% | -389.0% | ||
| Q2 24 | 11.7% | -966.2% | ||
| Q1 24 | 16.9% | — |
资本支出强度CTLPPHAT
| Q4 25 | 4.8% | 0.4% | ||
| Q3 25 | 4.2% | 0.1% | ||
| Q2 25 | 6.2% | 0.2% | ||
| Q1 25 | 5.1% | 0.1% | ||
| Q4 24 | 5.8% | 0.5% | ||
| Q3 24 | 5.4% | 0.3% | ||
| Q2 24 | 7.9% | 0.6% | ||
| Q1 24 | 4.8% | — |
现金转化率CTLPPHAT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.38× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 0.10× | — | ||
| Q3 24 | -3.36× | — | ||
| Q2 24 | 6.47× | — | ||
| Q1 24 | 3.16× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTLP
| Transaction Processing | $47.9M | 61% |
| Subscription Revenue | $21.8M | 28% |
| Products | $9.0M | 11% |
PHAT
暂无分部数据
